Kymera Therapeutics

Kymera Therapeutics to Present at Upcoming September Investor Conferences

WATERTOWN, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will present at two upcoming